3National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in Chronic Kidney Dis- ease. Am J Kidney Dis, 2006,47(5 Suppl 3 ) : 145.
4Lin CC,Yang WC. Prognostic factors influencing the patency of hemodialysis vascular access:literature review and novel therapeu- tic modality by far infrared therapy. J Chin Med Assoc,2009,72 (3):109-116.
5Kimmel PL, Patel SS. Quality of life in patients with chronic kidney dis- ease:focus on end-stage renal disease treated with hemodialysis. Semin Nephrol, 2006,26( 1 ) : 68-79.
6Cohen SD, Patel SS, Khetpal P, et al. Pain, sleep disturbance, and qual- ity of life in patients with chronic kidney disease. Clin J Am Soc Nephrol, 2007,2(5 ) : 919 -925.
7Quinn RR, Lamping DL, I.ok CE, et al. The vascular access question- naire: assessing patient - reported views of vascular access. J Vasc Ac - cess, 2008,9(2) : 122-128.
8Cornel EB,Van Haarst EP,Schaarsberg RW,et al. The effect of biofeedback physical therapy in men with Chronic Pelvic Pain Syndrome Type Ⅲ. Eur Urol, 2005,47(5) :607-611.
9Daniela R, Michael ER. The role of psychological inter- ventions in the management of patients with chronic pain. Psychol Res Behav Manag,2011,4:41-49.
10Gian MM, Francesco P, Gianluca C, et al. Relaxation training for anx- iety: a ten-years systematic review with meta-analysis. BMC Psychia- try ,2008,8:41.
7Agarwal A, Raza M, Singhal V,et at. Evaluation of efficacy of tolterodine for prevention of eather-related bladder discomfort :aprospeetive,randomized, plaeebo-eontrolled doubled eblind study l J]. Anesth Analg, 2005,101 (4) : 1065-1067.
9Billing'ton A, Crane C, Jownally S, et al. Minimizing the complications associated with migrating catheters[J]. Br J Community Nuts,2008,13 (11 ) : 502-506.
10Chenoweth C, Saint S. Preventing catheter-associated urinary tract infec- tions in the intensive care unit[J]. Crit Care Clin, 2013,29 ( 1 ) : 19-32.
